Shares of Esperion Theraptc (ESPR) are trading 11% higher at a price of $8.335 at the time of this writing. While the Health Care sector is having a somewhat gloomy day in general, the company is rapidly outshining it's peers.


Esperion Theraptc has been trading between a 52-week high of $14.06 and a 52-week low of $3.28. The stock has a market cap of $555 Million.

Through scientific and clinical excellence, and a deep understanding of cholesterol biology, the experienced Lipid Management Team at Esperion is committed to developing new LDL-C lowering medicines that will make a substantial impact on reducing global cardiovascular disease, the leading cause of death around the world.

Esperion Therapeutics Inc. (ESPR) Stock Behavior Is Not Predictable
Stocks Register 08-13-22

Esperion Therapeutics: Positive Update On CLEAR Outcomes Trial Offsets Mixed Q2 Earnings
Seeking Alpha 08-08-22

How did Esperion Therapeutics Inc. (ESPR) fare last session?
US Post News 08-04-22

UPDATE: Credit Suisse Downgrades Esperion Therapeutics to Underperform
Investing.com 08-03-22

Esperion Therapeutics (ESPR) Q2 2022 Earnings Call Transcript
The Motley Fool 08-02-22